Merck Q2 net down 38.87% at Rs 15.77 cr

Company reported net profit of Rs 25.80 crore in the same quarter a year ago

<a href="http://www.shutterstock.com/pic-26356168/stock-photo-stock-market-crash-chart-raster-version.html?src=ToGmiM_JIPKrZ0JrXZWWzQ-2-65" target="_blank">Market Crash</a> image via Shutterstock
Press Trust of India New Delhi
Last Updated : Oct 23 2013 | 4:08 PM IST
Pharmaceutical company Merck Ltd today reported 38.87% decline in net profit at Rs 15.77 crore for the second quarter ended September 30, 2013, on the account of increase in expenses.

The company has reported net profit of Rs 25.80 crore in the same quarter a year ago.

Net sales in the quarter under review were at Rs 201.81 crore, an increase of 11.37% compared with Rs 181.2 in the corresponding quarter in the previous year, the company said in a BSE filing.

Also Read

Overall expenses during the quarter were at Rs 188.16 crore, an increase of 21.95% as against Rs 154.29 crore in the same quarter last year.

The company's shares were trading at Rs 573 per scrip during the afternoon trade, down 0.39% from its previous close, on the BSE.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 23 2013 | 4:05 PM IST

Next Story